Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 1
2008 4
2009 4
2010 1
2011 2
2012 3
2013 5
2014 3
2015 5
2016 8
2017 5
2018 6
2019 3
2020 6
2021 5
2022 6
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Results by year

Filters applied: . Clear all
Page 1
Impact of PNPLA3 rs738409 Polymorphism on the Development of Liver-Related Events in Patients With Nonalcoholic Fatty Liver Disease.
Rosso C, Caviglia GP, Birolo G, Armandi A, Pennisi G, Pelusi S, Younes R, Liguori A, Perez-Diaz-Del-Campo N, Nicolosi A, Govaere O, Castelnuovo G, Olivero A, Abate ML, Ribaldone DG, Fariselli P, Valenti L, Miele L, Petta S, Romero-Gomez M, Anstee QM, Bugianesi E. Rosso C, et al. Among authors: abate ml. Clin Gastroenterol Hepatol. 2023 Dec;21(13):3314-3321.e3. doi: 10.1016/j.cgh.2023.04.024. Epub 2023 May 4. Clin Gastroenterol Hepatol. 2023. PMID: 37149016 Free article.
The Predictive Role of Extracellular NAPRT for the Detection of Advanced Fibrosis in Biopsy-Proven Non-Alcoholic Fatty Liver Disease.
Armandi A, Colombo G, Rosso C, Caviglia GP, Olivero A, Abate ML, Guariglia M, Perez Diaz Del Campo N, Castelnuovo G, Ribaldone DG, Saracco GM, Genazzani AA, Bugianesi E. Armandi A, et al. Among authors: abate ml. Int J Mol Sci. 2023 Jan 7;24(2):1172. doi: 10.3390/ijms24021172. Int J Mol Sci. 2023. PMID: 36674688 Free PMC article.
Identification of the Best Cut-Off Value of PIVKA-II for the Surveillance of Patients at Risk of Hepatocellular Carcinoma Development.
Caviglia GP, Abate ML, Troshina G, Carucci P, Rolle E, Risso A, Burlone ME, Albè A, Crevola M, Musso EC, Rosso C, Armandi A, Olivero A, Minisini R, Saracco GM, Bugianesi E, Pirisi M, Ciancio A, Gaia S. Caviglia GP, et al. Among authors: abate ml. Biology (Basel). 2023 Jan 7;12(1):94. doi: 10.3390/biology12010094. Biology (Basel). 2023. PMID: 36671786 Free PMC article.
Expression of SARS-Cov-2 Entry Factors in Patients with Chronic Hepatitis.
Rosso C, Demelas C, Agostini G, Abate ML, Vernero M, Caviglia GP, D'Amato D, Armandi A, Tapparo M, Guariglia M, Troshina G, Massano A, Olivero A, Nicolosi A, Zannetti A, Pellicano R, Ciancio A, Saracco GM, Ribaldone DG, Bugianesi E, Fagoonee S. Rosso C, et al. Among authors: abate ml. Viruses. 2022 Oct 29;14(11):2397. doi: 10.3390/v14112397. Viruses. 2022. PMID: 36366497 Free PMC article.
Liver Cancer-Specific Isoform of Serine Protease Inhibitor Kazal for the Detection of Hepatocellular Carcinoma: Results from a Pilot Study in Patients with Dysmetabolic Liver Disease.
Caviglia GP, Nicolosi A, Abate ML, Carucci P, Rosso C, Rolle E, Armandi A, Aneli S, Olivero A, Risso A, Ribaldone DG, Fermer C, Saracco GM, Gaia S, Bugianesi E. Caviglia GP, et al. Among authors: abate ml. Curr Oncol. 2022 Jul 31;29(8):5457-5465. doi: 10.3390/curroncol29080431. Curr Oncol. 2022. PMID: 36005169 Free PMC article.
Clinical Application of Droplet Digital PCR for Hepatitis Delta Virus Quantification.
Olivero A, Rosso C, Ciancio A, Abate ML, Nicolosi A, Troshina G, Armandi A, Ribaldone DG, Saracco GM, Bugianesi E, Rizzetto M, Caviglia GP. Olivero A, et al. Among authors: abate ml. Biomedicines. 2022 Mar 29;10(4):792. doi: 10.3390/biomedicines10040792. Biomedicines. 2022. PMID: 35453541 Free PMC article.
Global multi-stakeholder endorsement of the MAFLD definition.
Méndez-Sánchez N, Bugianesi E, Gish RG, Lammert F, Tilg H, Nguyen MH, Sarin SK, Fabrellas N, Zelber-Sagi S, Fan JG, Shiha G, Targher G, Zheng MH, Chan WK, Vinker S, Kawaguchi T, Castera L, Yilmaz Y, Korenjak M, Spearman CW, Ungan M, Palmer M, El-Shabrawi M, Gruss HJ, Dufour JF, Dhawan A, Wedemeyer H, George J, Valenti L, Fouad Y, Romero-Gomez M, Eslam M; Global multi-stakeholder consensus on the redefinition of fatty liver disease. Méndez-Sánchez N, et al. Lancet Gastroenterol Hepatol. 2022 May;7(5):388-390. doi: 10.1016/S2468-1253(22)00062-0. Epub 2022 Mar 3. Lancet Gastroenterol Hepatol. 2022. PMID: 35248211 Free article. No abstract available.
Crosstalk between Irisin Levels, Liver Fibrogenesis and Liver Damage in Non-Obese, Non-Diabetic Individuals with Non-Alcoholic Fatty Liver Disease.
Armandi A, Rosso C, Nicolosi A, Caviglia GP, Abate ML, Olivero A, D'Amato D, Vernero M, Gaggini M, Saracco GM, Ribaldone DG, Leeming DJ, Gastaldelli A, Bugianesi E. Armandi A, et al. Among authors: abate ml. J Clin Med. 2022 Jan 27;11(3):635. doi: 10.3390/jcm11030635. J Clin Med. 2022. PMID: 35160087 Free PMC article.
Biomarkers of Oncogenesis, Adipose Tissue Dysfunction and Systemic Inflammation for the Detection of Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease.
Caviglia GP, Armandi A, Rosso C, Gaia S, Aneli S, Rolle E, Abate ML, Olivero A, Nicolosi A, Guariglia M, Ribaldone DG, Carucci P, Saracco GM, Bugianesi E. Caviglia GP, et al. Among authors: abate ml. Cancers (Basel). 2021 May 11;13(10):2305. doi: 10.3390/cancers13102305. Cancers (Basel). 2021. PMID: 34064999 Free PMC article.
59 results